SCHEMBL22064650

SCHEMBL22064650

CC(=O)Oc1ccc(COC2=CC(=O)N(C(=O)OC(C)(C)C)C2Cc2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 8/20 0.46
KLK5 Q9Y337 7/20 0.43
PRSS1 P07477 3/20 0.42
PRSS2 P07478 3/20 0.42
PRSS3 P35030 3/20 0.42
YAP1 P46937 3/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
PLA2G10 O15496 1/20 0.38
PLA2G5 P39877 1/20 0.38
LMNA P02545 1/20 0.38
GHSR Q92847 2/20 0.37
POLB P06746 1/20 0.36
MAOB P27338 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20734905 1.00 KLK7 (0.46) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734819 0.92 KLK7 (0.38) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734890 0.90 KLK7 (0.48) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734889 0.90 KLK7 (0.48) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734811 0.88 KLK7 (0.49) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734893 0.88 KLK7 (0.49) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734886 0.87 KLK7 (0.48) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734932 0.86 KLK7 (0.36) KLK7KLK5YAP1KMT2AGHSR
SCHEMBL20734924 0.86 KLK7 (0.36) KLK7KLK5YAP1KMT2AGHSR
SCHEMBL20734906 0.85 KLK7 (0.47) KLK7KLK5PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332440-B2 4-oxo-alkylated tetramic acid compound, and preparation method thereof BEIJING JOEKAI BIOTECH. LLC (CN) 2022-05-17 US disclosed
US-20200181081-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, AND PREPARATION METHOD THEREOF BEIJING JOEKAI BIOTECH. LLC (CN) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11332440-B2 4-oxo-alkylated tetramic acid compound, and preparation method thereof PSEN1, PSEN2, APP KLK7 4215/4885KLK5 3322/4885PRSS1 4332/4885
US-20200181081-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, AND PREPARATION METHOD THEREOF PSEN1, PSEN2, APP KLK7 4215/4885KLK5 3322/4885PRSS1 4332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.